Isbn: 9783030880194 - management of the breast and axilla in the neoadjuvant setting (10 risultati)

Perfeziona la tua ricerca

  • Libri (10)

  • Nuovo (10)

a

Fascia di prezzo personalizzata (EUR)

a

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato

      Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 126,26

      EUR 8,00 spedizione 
      Spedito da Italia a U.S.A.

      Quantità: 5 disponibili

      Condizione: new.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato

      Da: Brook Bookstore, Milano, MI, ItaliaBrook Bookstore

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 121,53

      EUR 27,99 spedizione 
      Spedito da Italia a U.S.A.

      Quantità: 5 disponibili

      Condizione: new.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato

      Da: Books Puddle, New York, NY, U.S.A.Books Puddle

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 211,05

      EUR 3,48 spedizione 
      Spedito in U.S.A.

      Quantità: 4 disponibili

      Condizione: New. 1st ed. 2022 edition NO-PA16APR2015-KAP.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato

      Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 224,71

      EUR 30,50 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion.As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.This text will provide a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians (surgeons, medical oncologists, radiation oncologists) and researchers with an interest in breast cancer. The book will review novel and evoling strategies in neoadjuvant systemic therapy forn early stage breast cancer, provide new perspectives about appropriate axillary imaging in anticipation of neoadjuvant systemic therapy, and describe new data on innovative surgical techniques and Radiation Oncology concepts designed to deescalate the extent and toxicity of local therapy while insuring oncologic safety. Several landmark clinical trials have been published in the last few years and will be placed in context with respect to current management. Integration of novel diagnostic and interventional breast imaging, local therapy (surgery and radiation) with contemporary systemic therapy will also be discussed.This text will serve as a very useful resource for physicians and researchers dealing with, and interested in, this challenging field. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato

      Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 282,44

      EUR 29,17 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 1 disponibili

      hardcover. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

    • Lingua: Inglese

      Editore: Springer, Berlin|Springer International Publishing|Springer, 2021

      3030880192 / 9783030880194

      • Rilegato
      • Print on Demand

      Da: moluna, Greven, Germaniamoluna

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 132,75

      EUR 48,99 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is und.

    • Lingua: Inglese

      Editore: Springer International Publishing Dez 2021, 2021

      3030880192 / 9783030880194

      • Rilegato
      • Print on Demand

      Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 160,49

      EUR 23,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 2 disponibili

      Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion. As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.This text will provide a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians (surgeons, medical oncologists, radiation oncologists) and researchers with an interest in breast cancer. The book will review novel and evoling strategies in neoadjuvant systemic therapy forn early stage breast cancer, provide new perspectives about appropriate axillary imaging in anticipation of neoadjuvant systemic therapy, and describe new data on innovative surgical techniques and Radiation Oncology concepts designed to deescalate the extent and toxicity of local therapy while insuring oncologic safety. Several landmark clinical trials have been published in the last few years and will be placed in context with respect to current management. Integration of novel diagnostic and interventional breast imaging, local therapy (surgery and radiation) with contemporary systemic therapy will also be discussed.This text will serve as a very useful resource for physicians and researchers dealing with, and interested in, this challenging field. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information. 392 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato
      • Print on Demand

      Da: Majestic Books, Hounslow, Regno UnitoMajestic Books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 219,85

      EUR 7,58 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. Print on Demand.

    • Lingua: Inglese

      Editore: Springer, Springer Dez 2021, 2021

      3030880192 / 9783030880194

      • Rilegato
      • Print on Demand

      Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 160,49

      EUR 60,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion.As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 392 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, 2021

      3030880192 / 9783030880194

      • Rilegato
      • Print on Demand

      Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 222,77

      EUR 9,95 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. PRINT ON DEMAND.